INT47615

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.58
First Reported 1980
Last Reported 2008
Negated 0
Speculated 0
Reported most in Abstract
Documents 9
Total Number 9
Disease Relevance 3.62
Pain Relevance 1.74

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nuclear envelope (DNASE1) extracellular region (DNASE1) nucleus (DNASE1)
Anatomy Link Frequency
hepatocytes 1
saliva 1
neutrophil 1
DNASE1 (Homo sapiens)
Pain Link Frequency Relevance Heat
halothane 1 99.90 Very High Very High Very High
anesthesia 6 98.08 Very High Very High Very High
Bile 4 97.92 Very High Very High Very High
Inflammatory response 4 97.68 Very High Very High Very High
fibrosis 11 94.64 High High
Inflammatory mediators 2 93.84 High High
Inflammation 16 92.16 High High
Chronic pancreatitis 4 87.92 High High
cytokine 1 80.64 Quite High
Buprenorphine 2 79.92 Quite High
Disease Link Frequency Relevance Heat
Apoptosis 59 99.04 Very High Very High Very High
Disease 12 98.10 Very High Very High Very High
INFLAMMATION 21 97.68 Very High Very High Very High
Pancreatitis 8 95.88 Very High Very High Very High
Cystic Fibrosis 11 94.64 High High
Benign Prostatic Hypertrophy 2 90.68 High High
Necrosis 1 87.64 High High
Cancer 29 87.28 High High
Death 12 85.92 High High
Breast Cancer 2 83.96 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The final preparation inhibited DNase I only, and had no inhibitory activity on pancreatic RNase, and trypsin.
Negative_regulation (inhibited) of DNase I
1) Confidence 0.58 Published 1980 Journal Gastroenterol. Jpn. Section Abstract Doc Link 7450390 Disease Relevance 0.13 Pain Relevance 0.15
Zn(2+) as high as 2 mM did not inhibit the DNase that took part in this apoptosis.
Negative_regulation (inhibit) of DNase associated with apoptosis
2) Confidence 0.48 Published 2004 Journal Life Sci. Section Abstract Doc Link 15135650 Disease Relevance 1.00 Pain Relevance 0.23
The expression of inhibitor of caspase activated DNase (ICAD) was reduced with the lapse of time.
Negative_regulation (inhibitor) of DNase
3) Confidence 0.45 Published 2005 Journal Zhonghua Zhong Liu Za Zhi Section Body Doc Link 16188123 Disease Relevance 0.16 Pain Relevance 0
Then clinical studies were made on the DNase I inhibitor in duodenal juice obtained after administration of Pancreozymin and Secretin to patients with various pancreatic diseases.
Negative_regulation (inhibitor) of DNase I associated with bile and pancreatitis
4) Confidence 0.43 Published 1980 Journal Gastroenterol. Jpn. Section Abstract Doc Link 7450390 Disease Relevance 0.25 Pain Relevance 0.26
The anesthetic halothane can inhibit the released neutral and acid DNase activities.
Negative_regulation (inhibit) of DNase associated with halothane
5) Confidence 0.38 Published 1995 Journal Z. Naturforsch., C, J. Biosci. Section Abstract Doc Link 7546035 Disease Relevance 0 Pain Relevance 0.22
However before adding such buffers saliva should be stored on ice (+4°C) to prevent bacterial (or other microbial growth) and to decrease salivary DNase activity.
Negative_regulation (decrease) of DNase in saliva
6) Confidence 0.05 Published 2008 Journal Current Genomics Section Body Doc Link PMC2674305 Disease Relevance 0 Pain Relevance 0
Since our experimental data indicated a decrease in acid DNase activity 24 h after exposure to SNP or peroxynitrite (Table 2), the inhibition of DNase II may be explained by the nitrosylation of its susceptible sites.
Negative_regulation (decrease) of DNase
7) Confidence 0.04 Published 2004 Journal Comp Hepatol Section Body Doc Link PMC516785 Disease Relevance 0.27 Pain Relevance 0
After in vitro exposure of isolated hepatocytes to SNP or peroxynitrite, the activity of both alkaline and acid DNase decreased in a dose-dependent fashion (Figure 2).
Negative_regulation (decreased) of DNase in hepatocytes
8) Confidence 0.03 Published 2004 Journal Comp Hepatol Section Body Doc Link PMC516785 Disease Relevance 0 Pain Relevance 0
For patients with established disease, recent and projected advances in therapies that are directed at neutrophil products, such as DNase, antioxidants, and protease inhibitors, hold great promise for limiting the consequences of the inflammatory response.
Negative_regulation (inhibitors) of DNase in neutrophil associated with inflammatory response and disease
9) Confidence 0.01 Published 2005 Journal Treat Respir Med Section Abstract Doc Link 16086599 Disease Relevance 1.81 Pain Relevance 0.88

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox